MiMedx Group Inc (MDXG)
7.455
+0.22
(+2.97%)
USD |
NASDAQ |
May 10, 16:00
7.455
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Free Cash Flow: 29.30M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.30M |
| December 31, 2023 | 24.79M |
| September 30, 2023 | 7.667M |
| June 30, 2023 | -3.886M |
| March 31, 2023 | -14.75M |
| December 31, 2022 | -20.41M |
| September 30, 2022 | -16.67M |
| June 30, 2022 | -11.50M |
| March 31, 2022 | -6.921M |
| December 31, 2021 | -5.20M |
| September 30, 2021 | -14.06M |
| June 30, 2021 | -25.12M |
| March 31, 2021 | -29.82M |
| December 31, 2020 | -34.49M |
| September 30, 2020 | -45.89M |
| June 30, 2020 | -43.93M |
| March 31, 2020 | -38.55M |
| December 31, 2019 | -41.16M |
| September 30, 2019 | -17.64M |
| June 30, 2019 | -12.98M |
| March 31, 2019 | 3.362M |
| December 31, 2018 | 26.38M |
| September 30, 2018 | 46.41M |
| June 30, 2018 | 61.71M |
| March 31, 2018 | 55.20M |
| Date | Value |
|---|---|
| December 31, 2017 | 57.81M |
| September 30, 2017 | 51.87M |
| June 30, 2017 | 36.52M |
| March 31, 2017 | 30.35M |
| December 31, 2016 | 17.64M |
| September 30, 2016 | 6.552M |
| June 30, 2016 | 10.90M |
| March 31, 2016 | 7.132M |
| December 31, 2015 | 12.98M |
| September 30, 2015 | 17.83M |
| June 30, 2015 | 20.45M |
| March 31, 2015 | 19.18M |
| December 31, 2014 | 14.24M |
| September 30, 2014 | 7.198M |
| June 30, 2014 | -0.2915M |
| March 31, 2014 | -2.527M |
| December 31, 2013 | -2.621M |
| September 30, 2013 | -4.239M |
| June 30, 2013 | -6.038M |
| March 31, 2013 | -4.806M |
| December 31, 2012 | -3.969M |
| September 30, 2012 | -4.587M |
| June 30, 2012 | -4.925M |
| March 31, 2012 | -6.584M |
| December 31, 2011 | -7.151M |
Free Cash Flow Range, Past 5 Years
-45.89M
Minimum
Sep 2020
29.30M
Maximum
Mar 2024
-16.06M
Average
-15.71M
Median
Free Cash Flow Benchmarks
| TELA Bio Inc | -41.47M |
| Amylyx Pharmaceuticals Inc | 10.68M |
| CEL-SCI Corp | -23.45M |
| AIM ImmunoTech Inc | -21.85M |
| IGC Pharma Inc | -6.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.978M |
| Cash from Investing (Quarterly) | -6.024M |
| Cash from Financing (Quarterly) | -33.47M |
| Free Cash Flow Per Share (Quarterly) | -0.0011 |
| Free Cash Flow to Equity (Quarterly) | 28.48M |
| Free Cash Flow to Firm (Quarterly) | 1.176M |
| Free Cash Flow Yield | 2.96% |